Fingerprint
Dive into the research topics of 'Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically